Clinical Trials Directory

Trials / Unknown

UnknownNCT02959008

Continous Assessment of Cerebral Autoregulation With Near-infrared Spectroscopy

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Yu Liyun · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Cerebral autoregulation can be explained by a tight coupling between oxygen supply and demand of the brain, and is essential to maintain a constant cerebral blood flow (CBF) in the context of changes in cerebral perfusion pressure. In this study, investigators use Near-infrared spectroscopy (NIRS) to monitor cerebral autoregulation.

Detailed description

Near-infrared spectroscopy (NIRS) is a noninvasive technology that real-time monitors cerebral tissue oxygenation index (TOI). Investigators use Near-infrared spectroscopy (NIRS) to monitor cerebral autoregulation of hypertensive participants and non-hypertensive participants.

Conditions

Interventions

TypeNameDescription
DEVICEmeasure TOI and BPBoth groups measure TOI and BP.

Timeline

Start date
2016-12-01
Primary completion
2018-12-01
Completion
2019-12-01
First posted
2016-11-08
Last updated
2016-11-16

Source: ClinicalTrials.gov record NCT02959008. Inclusion in this directory is not an endorsement.